{"protocolSection":{"identificationModule":{"nctId":"NCT01369069","orgStudyIdInfo":{"id":"15959"},"secondaryIdInfos":[{"id":"U01NS069498","type":"NIH","link":"https://reporter.nih.gov/quickSearch/U01NS069498"}],"organization":{"fullName":"University of Virginia","class":"OTHER"},"briefTitle":"Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial","officialTitle":"Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial","acronym":"SHINE"},"statusModule":{"statusVerifiedDate":"2019-12","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2012-04","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2018-11-19","type":"ACTUAL"},"completionDateStruct":{"date":"2018-11-19","type":"ACTUAL"},"studyFirstSubmitDate":"2011-06-06","studyFirstSubmitQcDate":"2011-06-07","studyFirstPostDateStruct":{"date":"2011-06-08","type":"ESTIMATED"},"resultsFirstSubmitDate":"2019-11-06","resultsFirstSubmitQcDate":"2019-11-26","resultsFirstPostDateStruct":{"date":"2019-12-16","type":"ACTUAL"},"lastUpdateSubmitDate":"2019-12-13","lastUpdatePostDateStruct":{"date":"2019-12-23","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Karen C. Johnston","investigatorTitle":"Principal Investigator","investigatorAffiliation":"University of Virginia"},"leadSponsor":{"name":"University of Virginia","class":"OTHER"},"collaborators":[{"name":"Neurological Emergencies Treatment Trials Network (NETT)","class":"NETWORK"},{"name":"Medical University of South Carolina","class":"OTHER"},{"name":"National Institute of Neurological Disorders and Stroke (NINDS)","class":"NIH"}]},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial is a multicenter, randomized, controlled clinical trial of 1400 patients that will include approximately 60 enrolling sites. The study hypotheses are that treatment of hyperglycemic acute ischemic stroke patients with targeted glucose concentration (80mg/dL - 130 mg/dL) will be safe and result in improved 3 month outcome after stroke.","detailedDescription":"Eligible subjects must be randomized within 12 hours of stroke symptom onset and either have type 2 diabetes and glucose concentrations of over 110 mg/dL or no history of diabetes and glucose concentrations of 150 mg/dL or higher on initial evaluation. The enrolling sites include the Neurological Emergencies Treatment Trials (NETT) sites as well as non NETT sites from all over the United States. The study evaluates the safety and efficacy of targeted glucose control (treatment group - IV insulin with target 80-130 mg/dl) verses control therapy of sub q insulin plus basal insulin with target glucose less than 180 mg/ dL."},"conditionsModule":{"conditions":["Acute Ischemic Stroke","Diabetes","Hyperglycemia"],"keywords":["stroke","diabetes","hyperglycemia"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"DOUBLE","whoMasked":["PARTICIPANT","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":1151,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"IV insulin drip with target glucose 80 mg/dL - 130 mg/dL","type":"EXPERIMENTAL","description":"The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.","interventionNames":["Drug: IV insulin to maintain target glucose concentration of 80-130 mg/dL"]},{"label":"Sub Q insulin to keep glucose less than 180 mg/dL","type":"ACTIVE_COMPARATOR","description":"This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL","interventionNames":["Drug: Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL"]}],"interventions":[{"type":"DRUG","name":"IV insulin to maintain target glucose concentration of 80-130 mg/dL","description":"Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target.","armGroupLabels":["IV insulin drip with target glucose 80 mg/dL - 130 mg/dL"],"otherNames":["Continuous intravenous insulin"]},{"type":"DRUG","name":"Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL","description":"Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL.","armGroupLabels":["Sub Q insulin to keep glucose less than 180 mg/dL"],"otherNames":["Sliding scale insulin"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of Participants With a Favorable Modified Rankin Scale (Yes/No)","description":"Favorable for the primary efficacy outcome is defined as modified Rankin Scale (mRS) score of 0 in patients with mild stroke (baseline NIHSS 3-7), mRS 0 or 1 in patients with moderate stroke (baseline NIHSS 8-14), and mRS 0, 1 or 2 in patients with severe stroke (baseline NIHSS 15-22) at 90 days with a pre-specified range of acceptable days of 76 -120 days. The mRS is a stroke outcome scale used to assess functional status after stroke. It consists of seven levels (0-6) where 0 indicates no residual symptoms at all, 5 indicates severe disability and 6 indicates death. The person collecting the mRS score was to be blinded to the participant's treatment group assignment.","timeFrame":"90 days (-14/+30 days)"},{"measure":"Number of Participants With Severe Hypoglycemia (Blood Glucose < 40mg/dL)","description":"Severe hypoglycemia (blood glucose \\< 40mg/dL) is the primary safety outcome and will be measured during the 72 hour treatment period.","timeFrame":"72 hours"}],"secondaryOutcomes":[{"measure":"Number of Participants With a Favorable NIHSS","description":"The NIHSS (National Institutes of Health Stroke Scale) score ranges from 0 to 42, with higher scores indicating greater neurological deficits. A favorable NIHSS was defined as a score of 0 or 1 on the NIHSS at 90 days post randomization.","timeFrame":"Follow up (Max 164 days)"},{"measure":"Number of Participants With a Favorable Barthel Index","description":"Favorable outcomes for the Barthel Index was defined as a score of 95-100 on the BI at 90 days post randomization. Barthel - Barthel Index for Activities of Daily Living (ADL) assesses functional independence, generally in stroke patients. Scores range from 0-100 with higher scores indicating greater ability to perform activities of daily living.","timeFrame":"Follow up (Max 164 days)"},{"measure":"Stroke Specific Quality of Life (SSQOL)","description":"Stroke Specific Quality of Life. Scores range from 1-5 with higher scores indicating better quality of life","timeFrame":"Follow up (Max 164 days)"}],"otherOutcomes":[{"measure":"Death","description":"Death from any cause","timeFrame":"90 days (+30 days)"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Age 18 years or older\n2. Clinical diagnosis of ischemic stroke defined as acute neurological deficit occurring in one or more cerebral vascular territories. Neuroimaging must be done to exclude intracranial hemorrhage (ICH).\n3. Randomization must be within 12 hours after stroke symptom onset and treatment is recommended, but not required, to begin within 3 hours after hospital arrival. If time of symptom onset is unclear or patient is awakening with stroke symptoms, the time of onset will be the time the patient was last known to be normal.\n4. Known history of type 2 diabetes mellitus and glucose \\>110 mg/dL OR admission blood glucose â‰¥150 mg/dL in those w/o known diabetes mellitus\n5. Baseline NIHSS score of 3-22\n6. Pre-stroke modified Rankin Scale score = 0 for patients with an NIHSS score of 3-7. Pre-stroke modified Rankin Scale score = 0 or 1 for patients with an NIHSS score of 8-22.\n7. Able to provide a valid informed consent to be in the study (self or their authorized legally accepted representative). The approved consent form must be signed and dated in accordance with federal and institutional guidelines.\n\nExclusion Criteria:\n\n1. Known history of type 1 diabetes mellitus\n2. Substantial pre-existing neurological or psychiatric illness that would confound the neurological assessment or other outcome assessment\n3. Having received experimental therapy for the enrollment stroke. IV tPA (up to 4.5 hrs) or IA tPA are allowed as are IA therapies including use of FDA cleared devices. Non FDA cleared devices are considered experimental and are excluded.\n4. Pregnant or breast-feeding at the time of study entry\n5. Other serious conditions that make the patient unlikely to survive 90 days\n6. Inability to follow the protocol or return for the 90 day follow up\n7. Renal dialysis (including hemo or peritoneal dialysis)","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Karen C Johnston, MD, MSc","affiliation":"University of Virginia","role":"STUDY_CHAIR"},{"name":"Christiana Hall, MD, MS","affiliation":"UT Southwestern","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Askiel Bruno, MD, MS","affiliation":"Augusta University","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Valerie Durkalski, PhD","affiliation":"Medical University of South Carolina","role":"PRINCIPAL_INVESTIGATOR"},{"name":"William Barsan, MD","affiliation":"University of Michigan","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Kevin Barrett, MD","affiliation":"Mayo Clinic","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"University of Arizona Medical Center - South Campus","city":"Tucson","state":"Arizona","zip":"85713","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"University of Arizona","city":"Tucson","state":"Arizona","zip":"85724","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"Long Beach Memorial Medical Center","city":"Long Beach","state":"California","zip":"90806","country":"United States","geoPoint":{"lat":33.76696,"lon":-118.18923}},{"facility":"Ronald Regan Medical Center","city":"Los Angeles","state":"California","zip":"90095","country":"United States","geoPoint":{"lat":34.05223,"lon":-118.24368}},{"facility":"San Francisco General Hospital","city":"San Francisco","state":"California","zip":"94110","country":"United States","geoPoint":{"lat":37.77493,"lon":-122.41942}},{"facility":"California Pacific Medical Center - Davies Campus","city":"San Francisco","state":"California","zip":"94114","country":"United States","geoPoint":{"lat":37.77493,"lon":-122.41942}},{"facility":"California Pacific Medical Center-Pacific Campus","city":"San Francisco","state":"California","zip":"94114","country":"United States","geoPoint":{"lat":37.77493,"lon":-122.41942}},{"facility":"UCSF Medical Center","city":"San Francisco","state":"California","zip":"94117","country":"United States","geoPoint":{"lat":37.77493,"lon":-122.41942}},{"facility":"Stanford University Medical Center","city":"Stanford","state":"California","zip":"94305","country":"United States","geoPoint":{"lat":37.42411,"lon":-122.16608}},{"facility":"MedStar Washington Hospital Center","city":"Washington","state":"District of Columbia","zip":"20010","country":"United States","geoPoint":{"lat":38.89511,"lon":-77.03637}},{"facility":"Mayo Clinic Jacksonville","city":"Jacksonville","state":"Florida","zip":"32224","country":"United States","geoPoint":{"lat":30.33218,"lon":-81.65565}},{"facility":"Jackson Memorial Hospital","city":"Miami","state":"Florida","zip":"33136","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Emory University Hospital - Midtown","city":"Atlanta","state":"Georgia","zip":"30308","country":"United States","geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"Emory University Hospital","city":"Atlanta","state":"Georgia","zip":"30322","country":"United States","geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"Grady Memorial Hospital","city":"Atlanta","state":"Georgia","zip":"30322","country":"United States","geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"Augusta University Medical Center","city":"Augusta","state":"Georgia","zip":"30912","country":"United States","geoPoint":{"lat":33.47097,"lon":-81.97484}},{"facility":"Northwestern Memorial Hospital","city":"Chicago","state":"Illinois","zip":"60611","country":"United States","geoPoint":{"lat":41.85003,"lon":-87.65005}},{"facility":"OSF Saint Francis Medical Center","city":"Peoria","state":"Illinois","zip":"61637","country":"United States","geoPoint":{"lat":40.69365,"lon":-89.58899}},{"facility":"University of Iowa Hospitals & Clinics","city":"Iowa City","state":"Iowa","zip":"52242","country":"United States","geoPoint":{"lat":41.66113,"lon":-91.53017}},{"facility":"University of Kansas Medical Center","city":"Kansas City","state":"Kansas","zip":"66160","country":"United States","geoPoint":{"lat":39.11417,"lon":-94.62746}},{"facility":"University of Kentucky","city":"Lexington","state":"Kentucky","zip":"40506","country":"United States","geoPoint":{"lat":37.98869,"lon":-84.47772}},{"facility":"University of Maryland Medical Center","city":"Baltimore","state":"Maryland","zip":"21201","country":"United States","geoPoint":{"lat":39.29038,"lon":-76.61219}},{"facility":"Tufts Medical Center","city":"Boston","state":"Massachusetts","zip":"02111","country":"United States","geoPoint":{"lat":42.35843,"lon":-71.05977}},{"facility":"Massachusetts General Hospital","city":"Boston","state":"Massachusetts","zip":"02114","country":"United States","geoPoint":{"lat":42.35843,"lon":-71.05977}},{"facility":"University of Michigan","city":"Ann Arbor","state":"Michigan","zip":"48109","country":"United States","geoPoint":{"lat":42.27756,"lon":-83.74088}},{"facility":"Detroit Receiving Hospital","city":"Detroit","state":"Michigan","zip":"48201","country":"United States","geoPoint":{"lat":42.33143,"lon":-83.04575}},{"facility":"Henry Ford Health System","city":"Detroit","state":"Michigan","zip":"48202","country":"United States","geoPoint":{"lat":42.33143,"lon":-83.04575}},{"facility":"Sinai-Grace Hospital","city":"Detroit","state":"Michigan","zip":"48235","country":"United States","geoPoint":{"lat":42.33143,"lon":-83.04575}},{"facility":"William Beaumont Hospital-Royal Oak","city":"Royal Oak","state":"Michigan","zip":"48073","country":"United States","geoPoint":{"lat":42.48948,"lon":-83.14465}},{"facility":"William Beaumont Hospital-Troy","city":"Troy","state":"Michigan","zip":"48085","country":"United States","geoPoint":{"lat":42.60559,"lon":-83.14993}},{"facility":"Hennepin County Medical Center","city":"Minneapolis","state":"Minnesota","zip":"55415","country":"United States","geoPoint":{"lat":44.97997,"lon":-93.26384}},{"facility":"University of Minnesota Medical Center, Fairview","city":"Minneapolis","state":"Minnesota","zip":"55455","country":"United States","geoPoint":{"lat":44.97997,"lon":-93.26384}},{"facility":"JFK Medical Center","city":"Edison","state":"New Jersey","zip":"08818","country":"United States","geoPoint":{"lat":40.51872,"lon":-74.4121}},{"facility":"Hackensack University Medical Center","city":"Hackensack","state":"New Jersey","zip":"07601","country":"United States","geoPoint":{"lat":40.88593,"lon":-74.04347}},{"facility":"Lincoln Medical and Mental Health Center","city":"Bronx","state":"New York","zip":"10451","country":"United States","geoPoint":{"lat":40.84985,"lon":-73.86641}},{"facility":"Kings County Hospital","city":"Brooklyn","state":"New York","zip":"11203","country":"United States","geoPoint":{"lat":40.6501,"lon":-73.94958}},{"facility":"SUNY Downstate University Hospital of Brooklyn","city":"Brooklyn","state":"New York","zip":"11203","country":"United States","geoPoint":{"lat":40.6501,"lon":-73.94958}},{"facility":"Buffalo General Medical Center","city":"Buffalo","state":"New York","zip":"14210","country":"United States","geoPoint":{"lat":42.88645,"lon":-78.87837}},{"facility":"The Mount Sinai Medical Center","city":"New York","state":"New York","zip":"10029","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Columbia University Medical Center","city":"New York","state":"New York","zip":"10032","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Weill Cornell Medical Center","city":"New York","state":"New York","zip":"10065","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Maimonides Medical Center","city":"New York","state":"New York","zip":"11219","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Summa Akron City Hospital","city":"Akron","state":"Ohio","zip":"44307","country":"United States","geoPoint":{"lat":41.08144,"lon":-81.51901}},{"facility":"University of Cincinnati","city":"Cincinnati","state":"Ohio","zip":"45221","country":"United States","geoPoint":{"lat":39.12713,"lon":-84.51435}},{"facility":"Wexner Medical Center","city":"Columbus","state":"Ohio","zip":"43210","country":"United States","geoPoint":{"lat":39.96118,"lon":-82.99879}},{"facility":"Miami Valley Hospital","city":"Dayton","state":"Ohio","zip":"45409","country":"United States","geoPoint":{"lat":39.75895,"lon":-84.19161}},{"facility":"Abington Memorial Hospital","city":"Abington","state":"Pennsylvania","zip":"19001","country":"United States","geoPoint":{"lat":40.12067,"lon":-75.11795}},{"facility":"Penn State Hershey Medical Center","city":"Hershey","state":"Pennsylvania","zip":"17033","country":"United States","geoPoint":{"lat":40.28592,"lon":-76.65025}},{"facility":"Thomas Jefferson University Hospital","city":"Philadelphia","state":"Pennsylvania","zip":"19102","country":"United States","geoPoint":{"lat":39.95233,"lon":-75.16379}},{"facility":"Hospital of the University of Pennsylvania","city":"Philadelphia","state":"Pennsylvania","zip":"19104","country":"United States","geoPoint":{"lat":39.95233,"lon":-75.16379}},{"facility":"Temple University Hospital","city":"Philadelphia","state":"Pennsylvania","zip":"19140","country":"United States","geoPoint":{"lat":39.95233,"lon":-75.16379}},{"facility":"Allegheny General Hospital","city":"Pittsburgh","state":"Pennsylvania","zip":"15212","country":"United States","geoPoint":{"lat":40.44062,"lon":-79.99589}},{"facility":"UPMC Presbyterian","city":"Pittsburgh","state":"Pennsylvania","zip":"15213","country":"United States","geoPoint":{"lat":40.44062,"lon":-79.99589}},{"facility":"UPMC - Mercy","city":"Pittsburgh","state":"Pennsylvania","zip":"15219","country":"United States","geoPoint":{"lat":40.44062,"lon":-79.99589}},{"facility":"WellSpan York Hospital","city":"York","state":"Pennsylvania","zip":"17403","country":"United States","geoPoint":{"lat":39.9626,"lon":-76.72774}},{"facility":"St. Thomas Neuroscience Research Institute","city":"Nashville","state":"Tennessee","zip":"37205","country":"United States","geoPoint":{"lat":36.16589,"lon":-86.78444}},{"facility":"Vanderbilt University Medical Center","city":"Nashville","state":"Tennessee","zip":"37232","country":"United States","geoPoint":{"lat":36.16589,"lon":-86.78444}},{"facility":"Dell Seton Medical Center at UT","city":"Austin","state":"Texas","zip":"78701","country":"United States","geoPoint":{"lat":30.26715,"lon":-97.74306}},{"facility":"Seton Medical Center","city":"Austin","state":"Texas","zip":"78705","country":"United States","geoPoint":{"lat":30.26715,"lon":-97.74306}},{"facility":"UT Southwestern-Parkland Memorial Hospital","city":"Dallas","state":"Texas","zip":"75390","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"UT Southwestern-Zale Lipshy University Hospital","city":"Dallas","state":"Texas","zip":"75390","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"Valley Baptist Medical Center","city":"Harlingen","state":"Texas","zip":"78552","country":"United States","geoPoint":{"lat":26.19063,"lon":-97.6961}},{"facility":"Baylor College of Medicine","city":"Houston","state":"Texas","zip":"77030","country":"United States","geoPoint":{"lat":29.76328,"lon":-95.36327}},{"facility":"Memorial Herman Hospital","city":"Houston","state":"Texas","zip":"77030","country":"United States","geoPoint":{"lat":29.76328,"lon":-95.36327}},{"facility":"University of Utah","city":"Salt Lake City","state":"Utah","zip":"84132","country":"United States","geoPoint":{"lat":40.76078,"lon":-111.89105}},{"facility":"University of Virginia","city":"Charlottesville","state":"Virginia","zip":"22908","country":"United States","geoPoint":{"lat":38.02931,"lon":-78.47668}},{"facility":"Virginia Commonwealth University","city":"Richmond","state":"Virginia","zip":"23298","country":"United States","geoPoint":{"lat":37.55376,"lon":-77.46026}},{"facility":"Harborview Medical Center","city":"Seattle","state":"Washington","zip":"98104","country":"United States","geoPoint":{"lat":47.60621,"lon":-122.33207}},{"facility":"West Virginia University","city":"Morgantown","state":"West Virginia","zip":"26506","country":"United States","geoPoint":{"lat":39.62953,"lon":-79.9559}},{"facility":"Froedtert Memorial Hospital","city":"Milwaukee","state":"Wisconsin","zip":"53226","country":"United States","geoPoint":{"lat":43.0389,"lon":-87.90647}}]},"referencesModule":{"references":[{"pmid":"31334795","type":"RESULT","citation":"Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, Fansler A, Van de Bruinhorst K, Janis S, Durkalski-Mauldin VL; Neurological Emergencies Treatment Trials Network and the SHINE Trial Investigators. Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial. JAMA. 2019 Jul 23;322(4):326-335. doi: 10.1001/jama.2019.9346. Erratum In: JAMA. 2019 Nov 5;322(17):1718."},{"pmid":"36333676","type":"DERIVED","citation":"Arteaga DF, Ulep R, Kumar KK, Southerland AM, Conaway MR, Faber J, Wintermark M, Joyner D, Sharashidze V, Hirsch K, Giurgiutiu DV, Hannawi Y, Aziz Y, Shutter L, Visweswaran A, Williams A, Williams K, Gunter S, Haughey HM, Bruno A, Johnston KC, Patel VN; SHINE Trial Investigators. Collateral status, hyperglycemia, and functional outcome after acute ischemic stroke. BMC Neurol. 2022 Nov 4;22(1):408. doi: 10.1186/s12883-022-02943-4."},{"pmid":"25885963","type":"DERIVED","citation":"Connor JT, Broglio KR, Durkalski V, Meurer WJ, Johnston KC. The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial: an adaptive trial design case study. Trials. 2015 Mar 4;16:72. doi: 10.1186/s13063-015-0574-8."},{"pmid":"24499406","type":"DERIVED","citation":"Garofolo KM, Yeatts SD, Ramakrishnan V, Jauch EC, Johnston KC, Durkalski VL. The effect of covariate adjustment for baseline severity in acute stroke clinical trials with responder analysis outcomes. Trials. 2013 Apr 11;14:98. doi: 10.1186/1745-6215-14-98."},{"pmid":"23506245","type":"DERIVED","citation":"Bruno A, Durkalski VL, Hall CE, Juneja R, Barsan WG, Janis S, Meurer WJ, Fansler A, Johnston KC; SHINE investigators. The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke. Int J Stroke. 2014 Feb;9(2):246-51. doi: 10.1111/ijs.12045. Epub 2013 Mar 19."}],"seeAlsoLinks":[{"label":"General information of trial","url":"https://nett.umich.edu/clinical-trials/shine"}]}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"28977 patients were excluded after screening. Of those, 27344 did not meet eligibility criteria; 1156 were unable to provide informed consent or refused participation; 342 had other reasons and 135 did not specify a reason.","recruitmentDetails":"Between April 2012 and August 2018, a total of 70 United States sites were included in the trial, and 63 sites enrolled at least one patient.","groups":[{"id":"FG000","title":"IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL","description":"The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.\n\nIV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target."},{"id":"FG001","title":"Sub Q Insulin to Keep Glucose Less Than 180 mg/dL","description":"This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL\n\nStandard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"581"},{"groupId":"FG001","numSubjects":"570"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"564"},{"groupId":"FG001","numSubjects":"554"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"17"},{"groupId":"FG001","numSubjects":"16"}]}],"dropWithdraws":[{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"8"},{"groupId":"FG001","numSubjects":"9"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"9"},{"groupId":"FG001","numSubjects":"7"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL","description":"The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.\n\nIV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target."},{"id":"BG001","title":"Sub Q Insulin to Keep Glucose Less Than 180 mg/dL","description":"This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL\n\nStandard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL."},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"581"},{"groupId":"BG001","value":"570"},{"groupId":"BG002","value":"1151"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEDIAN","dispersionType":"INTER_QUARTILE_RANGE","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"66","lowerLimit":"57","upperLimit":"75"},{"groupId":"BG001","value":"66","lowerLimit":"57","upperLimit":"76"},{"groupId":"BG002","value":"66","lowerLimit":"57","upperLimit":"75"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"260"},{"groupId":"BG001","value":"264"},{"groupId":"BG002","value":"524"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"321"},{"groupId":"BG001","value":"306"},{"groupId":"BG002","value":"627"}]}]}]},{"title":"Ethnicity (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Hispanic or Latino","measurements":[{"groupId":"BG000","value":"87"},{"groupId":"BG001","value":"91"},{"groupId":"BG002","value":"178"}]},{"title":"Not Hispanic or Latino","measurements":[{"groupId":"BG000","value":"460"},{"groupId":"BG001","value":"449"},{"groupId":"BG002","value":"909"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"34"},{"groupId":"BG001","value":"30"},{"groupId":"BG002","value":"64"}]}]}]},{"title":"Race (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"American Indian or Alaska Native","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"2"}]},{"title":"Asian","measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"30"}]},{"title":"Native Hawaiian or Other Pacific Islander","measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"7"}]},{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"180"},{"groupId":"BG001","value":"154"},{"groupId":"BG002","value":"334"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"366"},{"groupId":"BG001","value":"368"},{"groupId":"BG002","value":"734"}]},{"title":"More than one race","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"23"},{"groupId":"BG002","value":"44"}]}]}]},{"title":"Final diagnosis","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Ischemic stroke","measurements":[{"groupId":"BG000","value":"542"},{"groupId":"BG001","value":"524"},{"groupId":"BG002","value":"1066"}]},{"title":"Transient ischemic attack","measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"20"}]},{"title":"Other","measurements":[{"groupId":"BG000","value":"31"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"65"}]}]}]},{"title":"Thrombolysis or Thrombectomy","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"Intravenous tPA","categories":[{"measurements":[{"groupId":"BG000","value":"372"},{"groupId":"BG001","value":"353"},{"groupId":"BG002","value":"725"}]}]},{"title":"Mechanical treatment","categories":[{"measurements":[{"groupId":"BG000","value":"74"},{"groupId":"BG001","value":"72"},{"groupId":"BG002","value":"146"}]}]},{"title":"Intraarterial drug therapy","categories":[{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"21"},{"groupId":"BG002","value":"35"}]}]},{"title":"None","categories":[{"measurements":[{"groupId":"BG000","value":"121"},{"groupId":"BG001","value":"124"},{"groupId":"BG002","value":"245"}]}]}]},{"title":"Medical History","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"Hypertension","categories":[{"measurements":[{"groupId":"BG000","value":"513"},{"groupId":"BG001","value":"502"},{"groupId":"BG002","value":"1015"}]}]},{"title":"Diabetes mellitus (Type 2)","categories":[{"measurements":[{"groupId":"BG000","value":"468"},{"groupId":"BG001","value":"455"},{"groupId":"BG002","value":"923"}]}]},{"title":"Hyperlipidemia","categories":[{"measurements":[{"groupId":"BG000","value":"350"},{"groupId":"BG001","value":"327"},{"groupId":"BG002","value":"677"}]}]},{"title":"Coronary artery disease","categories":[{"measurements":[{"groupId":"BG000","value":"159"},{"groupId":"BG001","value":"167"},{"groupId":"BG002","value":"326"}]}]},{"title":"Atrial fibrillation","categories":[{"measurements":[{"groupId":"BG000","value":"124"},{"groupId":"BG001","value":"106"},{"groupId":"BG002","value":"230"}]}]},{"title":"Previous Ischemic stroke","categories":[{"measurements":[{"groupId":"BG000","value":"104"},{"groupId":"BG001","value":"99"},{"groupId":"BG002","value":"203"}]}]},{"title":"Previous large vessel atherosclerosis","categories":[{"measurements":[{"groupId":"BG000","value":"42"},{"groupId":"BG001","value":"39"},{"groupId":"BG002","value":"81"}]}]}]},{"title":"Eligibility POC blood glucose (mg/dL)","paramType":"MEDIAN","dispersionType":"INTER_QUARTILE_RANGE","unitOfMeasure":"mg/dL","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"188","lowerLimit":"153","upperLimit":"250"},{"groupId":"BG001","value":"187","lowerLimit":"155","upperLimit":"248"},{"groupId":"BG002","value":"187.5","lowerLimit":"154","upperLimit":"250"}]}]}]},{"title":"Baseline NIHSS at randomization","paramType":"MEDIAN","dispersionType":"INTER_QUARTILE_RANGE","unitOfMeasure":"NIHSS score range: 0 to 42","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"7","lowerLimit":"5","upperLimit":"12"},{"groupId":"BG001","value":"7","lowerLimit":"5","upperLimit":"13"},{"groupId":"BG002","value":"7","lowerLimit":"5","upperLimit":"13"}]}]}]},{"title":"Baseline NIHSS category at randomization","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Mild (NIHSS 3-7)","measurements":[{"groupId":"BG000","value":"291"},{"groupId":"BG001","value":"291"},{"groupId":"BG002","value":"582"}]},{"title":"Moderate (NIHSS 8-14)","measurements":[{"groupId":"BG000","value":"177"},{"groupId":"BG001","value":"158"},{"groupId":"BG002","value":"335"}]},{"title":"Severe (NIHSS 15-22)","measurements":[{"groupId":"BG000","value":"113"},{"groupId":"BG001","value":"121"},{"groupId":"BG002","value":"234"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With a Favorable Modified Rankin Scale (Yes/No)","description":"Favorable for the primary efficacy outcome is defined as modified Rankin Scale (mRS) score of 0 in patients with mild stroke (baseline NIHSS 3-7), mRS 0 or 1 in patients with moderate stroke (baseline NIHSS 8-14), and mRS 0, 1 or 2 in patients with severe stroke (baseline NIHSS 15-22) at 90 days with a pre-specified range of acceptable days of 76 -120 days. The mRS is a stroke outcome scale used to assess functional status after stroke. It consists of seven levels (0-6) where 0 indicates no residual symptoms at all, 5 indicates severe disability and 6 indicates death. The person collecting the mRS score was to be blinded to the participant's treatment group assignment.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"90 days (-14/+30 days)","groups":[{"id":"OG000","title":"IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL","description":"The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.\n\nIV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target."},{"id":"OG001","title":"Sub Q Insulin to Keep Glucose Less Than 180 mg/dL","description":"This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL\n\nStandard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"581"},{"groupId":"OG001","value":"570"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"119"},{"groupId":"OG001","value":"123"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"It was hypothesized that intensive blood glucose control would be efficacious and safe in acute ischemic stroke patients compared to standard glucose control.","nonInferiorityType":"SUPERIORITY","pValue":"0.55","pValueComment":"The a priori threshold for statistical significance was 0.05.","statisticalMethod":"Regression, Logistic","paramType":"Risk Ratio (RR)","paramValue":"0.97","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.87","ciUpperLimit":"1.08","estimateComment":"Adjusted for baseline NIHSS strata (3-7, 8-14, 15-22) and thrombolysis use (Yes/No; includes both IV and IA therapies). Multiple imputation was used for missing data."}]},{"type":"PRIMARY","title":"Number of Participants With Severe Hypoglycemia (Blood Glucose < 40mg/dL)","description":"Severe hypoglycemia (blood glucose \\< 40mg/dL) is the primary safety outcome and will be measured during the 72 hour treatment period.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"72 hours","groups":[{"id":"OG000","title":"IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL","description":"The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.\n\nIV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target."},{"id":"OG001","title":"Sub Q Insulin to Keep Glucose Less Than 180 mg/dL","description":"This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL\n\nStandard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"581"},{"groupId":"OG001","value":"570"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"0"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Fisher Exact","paramType":"Risk Difference (RD)","paramValue":"2.58","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"1.29","ciUpperLimit":"3.87","estimateComment":"The data of the estimation parameter and the confidence intervals were presented as percentages."}]},{"type":"SECONDARY","title":"Number of Participants With a Favorable NIHSS","description":"The NIHSS (National Institutes of Health Stroke Scale) score ranges from 0 to 42, with higher scores indicating greater neurological deficits. A favorable NIHSS was defined as a score of 0 or 1 on the NIHSS at 90 days post randomization.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Follow up (Max 164 days)","groups":[{"id":"OG000","title":"IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL","description":"The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.\n\nIV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target."},{"id":"OG001","title":"Sub Q Insulin to Keep Glucose Less Than 180 mg/dL","description":"This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL\n\nStandard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"348"},{"groupId":"OG001","value":"371"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"152"},{"groupId":"OG001","value":"166"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.77","statisticalMethod":"Chi-squared","paramType":"Risk Difference (RD)","paramValue":"-1.07","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-8.33","ciUpperLimit":"6.20","estimateComment":"The data of the estimation parameter and the confidence intervals were presented as percentages."}]},{"type":"SECONDARY","title":"Number of Participants With a Favorable Barthel Index","description":"Favorable outcomes for the Barthel Index was defined as a score of 95-100 on the BI at 90 days post randomization. Barthel - Barthel Index for Activities of Daily Living (ADL) assesses functional independence, generally in stroke patients. Scores range from 0-100 with higher scores indicating greater ability to perform activities of daily living.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Follow up (Max 164 days)","groups":[{"id":"OG000","title":"IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL","description":"The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.\n\nIV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target."},{"id":"OG001","title":"Sub Q Insulin to Keep Glucose Less Than 180 mg/dL","description":"This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL\n\nStandard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"491"},{"groupId":"OG001","value":"477"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"271"},{"groupId":"OG001","value":"261"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.88","statisticalMethod":"Chi-squared","paramType":"Risk Difference (RD)","paramValue":"0.48","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-5.79","ciUpperLimit":"6.75","estimateComment":"The data of the estimation parameter and the confidence intervals were presented as percentages."}]},{"type":"SECONDARY","title":"Stroke Specific Quality of Life (SSQOL)","description":"Stroke Specific Quality of Life. Scores range from 1-5 with higher scores indicating better quality of life","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","unitOfMeasure":"score on a scale","timeFrame":"Follow up (Max 164 days)","groups":[{"id":"OG000","title":"IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL","description":"The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.\n\nIV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target."},{"id":"OG001","title":"Sub Q Insulin to Keep Glucose Less Than 180 mg/dL","description":"This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL\n\nStandard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"442"},{"groupId":"OG001","value":"432"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.75","lowerLimit":"2.98","upperLimit":"4.40"},{"groupId":"OG001","value":"3.69","lowerLimit":"3.02","upperLimit":"4.46"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.74","statisticalMethod":"Wilcoxon (Mann-Whitney)","paramType":"Median Difference (Final Values)","paramValue":"0.06","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.13","ciUpperLimit":"0.25"}]},{"type":"OTHER_PRE_SPECIFIED","title":"Death","description":"Death from any cause","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"90 days (+30 days)","groups":[{"id":"OG000","title":"IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL","description":"The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.\n\nIV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target."},{"id":"OG001","title":"Sub Q Insulin to Keep Glucose Less Than 180 mg/dL","description":"This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL\n\nStandard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"581"},{"groupId":"OG001","value":"570"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"65"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.24","statisticalMethod":"Chi-squared","paramType":"Risk Ratio (RR)","paramValue":"0.82","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.58","ciUpperLimit":"1.15"}]}]},"adverseEventsModule":{"frequencyThreshold":"0","timeFrame":"Non-serious adverse events were assessed and reported through the treatment period (up to 72 hours). Serious adverse events were reported throughout the study period (randomization through end of study; end of study was 90 days post randomization or earlier if a participant died or withdrew consent).","eventGroups":[{"id":"EG000","title":"IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL","description":"The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.\n\nIV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target.","deathsNumAffected":54,"deathsNumAtRisk":581,"seriousNumAffected":209,"seriousNumAtRisk":581,"otherNumAffected":384,"otherNumAtRisk":581},{"id":"EG001","title":"Sub Q Insulin to Keep Glucose Less Than 180 mg/dL","description":"This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL\n\nStandard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL.","deathsNumAffected":65,"deathsNumAtRisk":570,"seriousNumAffected":198,"seriousNumAtRisk":570,"otherNumAffected":134,"otherNumAtRisk":570}],"seriousEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Acute coronary syndrome","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Acute myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":8,"numAtRisk":581},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":570}]},{"term":"Atrial flutter","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Cardiac arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":7,"numAtRisk":581},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":570}]},{"term":"Cardiac failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":3,"numAtRisk":581},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":570}]},{"term":"Cardiac failure congestive","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Cardio-respiratory arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Cardiogenic shock","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Ischaemic cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":570}]},{"term":"Myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":581},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Supraventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Ventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Eye disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Dysphagia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Gastric haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Gastrointestinal disorder","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":570}]},{"term":"Gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Haematemesis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":570}]},{"term":"Small intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":570}]},{"term":"Device occlusion","organSystem":"General disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Multi-organ failure","organSystem":"General disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"General disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Sudden death","organSystem":"General disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Cholecystitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":570}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Clostridium difficile colitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Endocarditis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":15,"numAtRisk":581},{"groupId":"EG001","numEvents":14,"numAffected":14,"numAtRisk":570}]},{"term":"Sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":581},{"groupId":"EG001","numEvents":15,"numAffected":14,"numAtRisk":570}]},{"term":"Septic shock","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Skin infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":581},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":570}]},{"term":"Urosepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Wound infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Brain herniation","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Hip fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"International normalised ratio increased","organSystem":"Investigations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Acidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Diabetic ketoacidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Hyperglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":570}]},{"term":"Hyperkalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Hypernatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Hypoglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":28,"numAffected":21,"numAtRisk":581},{"groupId":"EG001","numEvents":4,"numAffected":2,"numAtRisk":570}]},{"term":"Hypokalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Hyponatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Vitamin B12 deficiency","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Musculoskeletal chest pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Uterine cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Brain oedema","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":581},{"groupId":"EG001","numEvents":11,"numAffected":11,"numAtRisk":570}]},{"term":"Cerebral haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":4,"numAtRisk":581},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":570}]},{"term":"Cerebrovascular accident","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":581},{"groupId":"EG001","numEvents":12,"numAffected":12,"numAtRisk":570}]},{"term":"Convulsion","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":581},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":570}]},{"term":"Embolic stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":5,"numAffected":4,"numAtRisk":570}]},{"term":"Haemorrhage intracranial","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":581},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":570}]},{"term":"Haemorrhagic transformation stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":37,"numAffected":36,"numAtRisk":581},{"groupId":"EG001","numEvents":28,"numAffected":27,"numAtRisk":570}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Hydrocephalus","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Ischaemic stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":16,"numAtRisk":581},{"groupId":"EG001","numEvents":21,"numAffected":16,"numAtRisk":570}]},{"term":"Neurological decompensation","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":581},{"groupId":"EG001","numEvents":18,"numAffected":17,"numAtRisk":570}]},{"term":"Neurological symptom","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Stroke in evolution","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":9,"numAtRisk":581},{"groupId":"EG001","numEvents":11,"numAffected":11,"numAtRisk":570}]},{"term":"Subarachnoid haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Transient ischaemic attack","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":4,"numAtRisk":581},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":570}]},{"term":"Tremor","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Agitation","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Anxiety","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Delirium","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Mental disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Haematuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Renal failure acute","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":581},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":570}]},{"term":"Acute respiratory distress syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Acute respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":570}]},{"term":"Aspiration","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Pneumonia aspiration","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":5,"numAtRisk":581},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":570}]},{"term":"Pulmonary embolism","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":581},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":570}]},{"term":"Pulmonary oedema","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Respiratory distress","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":15,"numAtRisk":581},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":570}]},{"term":"Angioedema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Hospitalisation","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Deep vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":4,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Embolism","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Haematoma","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Shock haemorrhagic","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]}],"otherEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":570}]},{"term":"Leukocytosis","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Acute myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":9,"numAtRisk":581},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":570}]},{"term":"Bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Cardiac failure congestive","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Ischaemic cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Supraventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Ventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Hypothyroidism","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Eye disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Dysphagia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":5,"numAtRisk":581},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":570}]},{"term":"Catheter site haematoma","organSystem":"General disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"General disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Pain","organSystem":"General disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":581},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Hypersensitivity","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Endocarditis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":570}]},{"term":"Sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":12,"numAtRisk":581},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":570}]},{"term":"Contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Activated partial thromboplastin time prolonged","organSystem":"Investigations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Blood chloride increased","organSystem":"Investigations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Blood cholesterol increased","organSystem":"Investigations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Blood creatinine decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Blood potassium decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Blood sodium decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Carbon dioxide decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"High density lipoprotein decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"International normalised ratio increased","organSystem":"Investigations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Investigations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":8,"numAtRisk":581},{"groupId":"EG001","numEvents":12,"numAffected":9,"numAtRisk":570}]},{"term":"Red cell distribution width increased","organSystem":"Investigations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Troponin increased","organSystem":"Investigations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"White blood cell count increased","organSystem":"Investigations","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Acidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Diabetic ketoacidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Hyperchloraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Hyperglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Hyperkalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Hyperlipidaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Hypernatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Hypoalbuminaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Hypocalcaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Hypoglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":574,"numAffected":311,"numAtRisk":581},{"groupId":"EG001","numEvents":26,"numAffected":16,"numAtRisk":570}]},{"term":"Hypokalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":14,"numAffected":14,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Hypomagnesaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Hyponatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Hypophosphataemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Vitamin B12 deficiency","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Muscle spasms","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":581},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":570}]},{"term":"Brain oedema","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Carotid artery stenosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Cerebral haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Cerebrovascular accident","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Convulsion","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Haemorrhage intracranial","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Haemorrhagic transformation stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":23,"numAffected":23,"numAtRisk":581},{"groupId":"EG001","numEvents":13,"numAffected":13,"numAtRisk":570}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":11,"numAtRisk":581},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":570}]},{"term":"Neurological decompensation","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":10,"numAtRisk":581},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":570}]},{"term":"Neurological symptom","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Stroke in evolution","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Subarachnoid haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Tremor","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Agitation","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Anxiety","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Delirium","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Mental disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Haematuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Renal failure acute","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Urinary retention","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Acute respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Hypoxia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Pleural effusion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Pulmonary embolism","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Pulmonary oedema","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Respiratory distress","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Angioedema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Deep vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Haematoma","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":570}]},{"term":"Haemorrhage","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":581},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":570}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":581},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":570}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":581},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":570}]},{"term":"Malignant hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Other (combined AEs happened only once)","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]},{"term":"Shock haemorrhagic","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (10.0)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":581},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":570}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"pointOfContact":{"title":"Karen C. Johnston, MD","organization":"University of Virginia","email":"kj4v@virginia.edu","phone":"434 924-5323"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot","hasProtocol":true,"hasSap":false,"hasIcf":false,"label":"Study Protocol","date":"2012-10-23","uploadDate":"2019-09-11T11:35","filename":"Prot_000.pdf","size":587777},{"typeAbbrev":"SAP","hasProtocol":false,"hasSap":true,"hasIcf":false,"label":"Statistical Analysis Plan","date":"2015-01-08","uploadDate":"2019-09-11T11:37","filename":"SAP_001.pdf","size":219452}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000006943","term":"Hyperglycemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000044882","term":"Glucose Metabolism Disorders"},{"id":"D000008659","term":"Metabolic Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M6805","name":"Diabetes Mellitus","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Acute Ischemic Stroke","relevance":"HIGH"},{"id":"M9684","name":"Hyperglycemia","asFound":"Hyperglycemia","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M11329","name":"Metabolic Diseases","relevance":"LOW"},{"id":"M25093","name":"Glucose Metabolism Disorders","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC18","name":"Nutritional and Metabolic Diseases"},{"abbrev":"BC19","name":"Gland and Hormone Related Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000007328","term":"Insulin"},{"id":"C000557859","term":"Insulin, Globin Zinc"}],"ancestors":[{"id":"D000007004","term":"Hypoglycemic Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"}],"browseLeaves":[{"id":"M10055","name":"Insulin","asFound":"Per","relevance":"HIGH"},{"id":"M173072","name":"Insulin, Globin Zinc","asFound":"Per","relevance":"HIGH"},{"id":"M4544","name":"Benzocaine","relevance":"LOW"},{"id":"M17458","name":"Zinc","relevance":"LOW"},{"id":"M9744","name":"Hypoglycemic Agents","relevance":"LOW"},{"id":"T433","name":"Tannic Acid","relevance":"LOW"}],"browseBranches":[{"abbrev":"Hypo","name":"Hypoglycemic Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"CNSDep","name":"Central Nervous System Depressants"},{"abbrev":"Micro","name":"Micronutrients"},{"abbrev":"Ot","name":"Other Dietary Supplements"}]}},"hasResults":true}